Business News • PR NewsWire • Innovent Organized a Forum Discussing the Pending Launch of its Anti PD-1 Tyvyt® (Sintilimab injection) as Part of the National Mega Innovation Program in Beijing

Innovent Organized a Forum Discussing the Pending Launch of its Anti PD-1 Tyvyt® (Sintilimab injection) as Part of the National Mega Innovation Program in Beijing

Innovent Organized a Forum Discussing the Pending Launch of its Anti PD-1 Tyvyt® (Sintilimab injection) as Part of the National Mega Innovation Program in Beijing

BEIJING, Feb. 22, 2019 /PRNewswire/ -- The Forum for the National Mega Innovation Program in conjunction with the press conference on the launch of Tyvyt® (fully human anti-PD-1 therapeutic monoclonal antibody, generic name: sintilimab injection), hosted by Innovent Biologics, Inc....

View More : https://www.prnewswire.com:443/news-releases/innovent-organized-a-forum-discussing-the-pending-launch-of-its-anti-pd-1-t...

Releted News by prnewswire

myFC Showcases Prototype of LAMINA INcase for Samsung Galaxy S10 at MWC Barcelona

Market Making Services Agreement for Sasol BEE Ordinary ('SOLBE1') Shares Entered Into With Ngonyama Capital Proprietary Limited ('Ngonyama Capital')

AEDAS Homes hat laut seinem Abschlussbericht 2018 Gewinne erwirtschaftet und alle seine Ziele erreicht

Innovent Organized a Forum Discussing the Pending Launch of its Anti PD-1 Tyvyt® (Sintilimab injection) as Part of the National Mega Innovation Program in Beijing

SK Innovation to Jointly Develop Key Material for Next-Generation Battery with US Company

Former CFTC Lawyer Partners with Jenga BCG to Launch Regulatory Advisory Firm for Blockchain Business